The Care Up
The US Food and Drug Administration will review a pharmaceutical company’s application for the first over-the-counter contraceptive in November 2022, with a decision expected in the first half of 2023. Approved OTC hormonal contraceptive products do not require a prescription and are considered self-care defined as “the practice of health-conscious …
Read More »pharmacists and pharmacies could play an ever-increasing role in reproductive health care
